Thomas N. Wight

31.5k total citations · 2 hit papers
328 papers, 25.1k citations indexed

About

Thomas N. Wight is a scholar working on Cell Biology, Molecular Biology and Cancer Research. According to data from OpenAlex, Thomas N. Wight has authored 328 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Cell Biology, 169 papers in Molecular Biology and 83 papers in Cancer Research. Recurrent topics in Thomas N. Wight's work include Proteoglycans and glycosaminoglycans research (210 papers), Glycosylation and Glycoproteins Research (99 papers) and Protease and Inhibitor Mechanisms (79 papers). Thomas N. Wight is often cited by papers focused on Proteoglycans and glycosaminoglycans research (210 papers), Glycosylation and Glycoproteins Research (99 papers) and Protease and Inhibitor Mechanisms (79 papers). Thomas N. Wight collaborates with scholars based in United States, Japan and Australia. Thomas N. Wight's co-authors include Michael G. Kinsella, Stephen P. Evanko, Susan Potter‐Perigo, Alan D. Snow, Alan Chait, Hannu Järveläinen, Mervyn J. Merrilees, Kathleen R. Braun, Russell Ross and Paul L. Bollyky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Thomas N. Wight

326 papers receiving 24.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human tissue-engineered blood vessels for adult arterial revascularization

2006 839 citations Nicolas L’Heureux, Nathalie Dusserre et al. profile →
The extracellular matrix: an active or passive player in fibrosis?

2011 453 citations Thomas N. Wight, Susan Potter‐Perigo profile →

Peers

Countries citing papers authored by Thomas N. Wight

Since Specialization

Citations

This map shows the geographic impact of Thomas N. Wight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Wight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Wight more than expected).

Fields of papers citing papers by Thomas N. Wight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Wight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Wight. The network helps show where Thomas N. Wight may publish in the future.

Co-authorship network of co-authors of Thomas N. Wight

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Wight. A scholar is included among the top collaborators of Thomas N. Wight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Wight. Thomas N. Wight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hymecromone Promotes Longevity and Insulin Sensitivity in Mice 2024 ·Cells ·Nadine Nagy, (unknown), Gernot Kaber, Darko Stefanovski, (unknown), (unknown), (unknown), Saranya Chidambaranathan Reghupaty, Thomas N. Wight, Robert B. Vernon, (unknown), Payton L. Marshall, Carlos Medina, (unknown), (unknown), Rudolph D. Paladini, Stavros Garantziotis, Joshua W. Knowles, Paul L. Bollyky	0
2	Inhibition of hyaluronan synthesis prevents β-cell loss in obesity-associated type 2 diabetes 2023 ·Matrix Biology ·Nadine Nagy, Gernot Kaber, Vivekananda Gupta Sunkari, Payton L. Marshall, (unknown), Hedwich F. Kuipers, Heather D. Ishak, Marika Bogdani, Rebecca L. Hull, Maria Grandoch, Jens W. Fischer, Tracey McLaughlin, Thomas N. Wight, Paul L. Bollyky	5
3	A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease 2014 ·Matrix Biology ·Mary Y. Chang, Yoshinori Tanino, Veronika Vidová, Michael G. Kinsella, Christina K. Chan, Pamela Y. Johnson, Thomas N. Wight, Charles W. Frevert	64
4	Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease 2014 ·Matrix Biology ·Mary Y. Chang, Yoshinori Tanino, Veronika Vidová, Michael G. Kinsella, Christina K. Chan, Pamela Y. Johnson, Thomas N. Wight, Charles W. Frevert	25
5	The Detection of Glycosaminoglycans in Pancreatic Islets and Lymphoid Tissues 2014 ·Methods in molecular biology ·Marika Bogdani, Charmaine J. Simeonovic, Nadine Nagy, Pamela Y. Johnson, Christina K. Chan, Thomas N. Wight	8
6	Versican and the control of inflammation 2014 ·Matrix Biology ·Thomas N. Wight, Inkyung Kang, Mervyn J. Merrilees	172
7	Syndecan-4 Regulates Early Neutrophil Migration and Pulmonary Inflammation in Response to Lipopolysaccharide 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Yoshinori Tanino, Mary Y. Chang, Xintao Wang, Sean E. Gill, Shawn Skerrett, John K. McGuire, Suguru Sato, Takefumi Nikaido, Tetsuhito Kojima, Mitsuru Munakata, (unknown), William C. Parks, Thomas R. Martin, Thomas N. Wight, Charles W. Frevert	51
8	Kinetics of Chemokine–Glycosaminoglycan Interactions Control Neutrophil Migration into the Airspaces of the Lungs 2010 ·The Journal of Immunology ·(unknown), Deirdre R. Coombe, Sean E. Gill, Warren C. Kett, Osamu Kajikawa, Amanda E. I. Proudfoot, Timothy N. C. Wells, William C. Parks, Thomas N. Wight, Thomas R. Martin, Charles W. Frevert	86
9	Developing Vasculature and Stroma in Engineered Human Myocardium 2010 ·Tissue Engineering Part A ·Kareen L. Kreutziger, Veronica Muskheli, Pamela Y. Johnson, Kathleen R. Braun, Thomas N. Wight, Charles E. Murry	53
10	Expression of Versican Isoform V3 in the Absence of Ascorbate Improves Elastogenesis in Engineered Vascular Constructs 2009 ·Tissue Engineering Part A ·Paul Keire, Nicolas L’Heureux, Robert B. Vernon, Mervyn J. Merrilees, Barry Starcher, Elena B. Okon, Nathalie Dusserre, Todd N. McAllister, Thomas N. Wight	25
11	Retrovirally Mediated Overexpression of Glycosaminoglycan-Deficient Biglycan in Arterial Smooth Muscle Cells Induces Tropoelastin Synthesis and Elastic Fiber Formation in Vitro and in Neointimae after Vascular Injury 2008 ·American Journal Of Pathology ·Jin‐Yong Hwang, Pamela Y. Johnson, Kathleen R. Braun, Aleksander Hinek, Jens W. Fischer, Kevin D. O’Brien, Barry Starcher, Alexander W. Clowes, Mervyn J. Merrilees, Thomas N. Wight	30
12	SPARC-thrombospondin-2-double-null Mice Exhibit Enhanced Cutaneous Wound Healing and Increased Fibrovascular Invasion of Subcutaneous Polyvinyl Alcohol Sponges 2005 ·Journal of Histochemistry & Cytochemistry ·Pauli Puolakkainen, Amy D. Bradshaw, Rolf A. Brekken, May J. Reed, Themis R. Kyriakides, Sarah E. Funk, Michel D. Gooden, Robert B. Vernon, Thomas N. Wight, Paul Börnstein, E. Helene Sage	27
13	Propagation and Control of T Cell Responses by Heparan Sulfate-Bound IL-2 2003 ·The Journal of Immunology ·Lucile E. Wrenshall, Jeffrey L. Platt, (unknown), Thomas N. Wight, John D. Miller	26
14	Distinct Rat Aortic Smooth Muscle Cells Differ in Versican/PG-M Expression 1996 ·Arteriosclerosis Thrombosis and Vascular Biology ·Joan M. Lemire, Susan Potter‐Perigo, K. Hall, Thomas N. Wight, Stephen M. Schwartz	46
15	Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. 1995 ·Journal of Clinical Investigation ·Rashmin C. Savani, Chao Wang, Bo Yang, Shetuan Zhang, Michael G. Kinsella, Thomas N. Wight, Robert Stern, D.M. Nance, Eva A. Turley	166
16	Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system. 1993 ·PubMed ·S J Klebanoff, Michael G. Kinsella, Thomas N. Wight	61
17	A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. 1991 ·Journal of Histochemistry & Cytochemistry ·Alan D. Snow, Rachel Bramson, H Mar, Thomas N. Wight, Robert Kisilevsky	76
18	Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome 1990 ·Neurobiology of Aging ·Alan D. Snow, H Mar, David Nochlin, Raymond Sekiguchi, Koji Kimata, Y Koike, Thomas N. Wight	214
19	Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. 1990 ·PubMed ·Alan D. Snow, Thomas N. Wight, David Nochlin, Y Koike, Koji Kimata, S. J. DeArmond, S. B. Prusiner	141
20	Proteoglycans in Atherosclerosis. 1990 ·ACTA HISTOCHEMICA ET CYTOCHEMICA ·Thomas N. Wight	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact